SVYAX | VMVAX | SVYAX / VMVAX | |
Total Expense Ratio | 0.20 | 0.07 | 286% |
Annual Report Gross Expense Ratio | 0.62 | 0.07 | 886% |
Fund Existence | 17 years | 14 years | - |
Gain YTD | 8.738 | 5.198 | 168% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 291M | 31B | 1% |
Annual Yield % from dividends | 2.60 | 2.22 | 117% |
Returns for 1 year | 2.35 | 7.67 | 31% |
Returns for 3 years | -3.17 | 17.51 | -18% |
Returns for 5 years | 3.82 | 65.15 | 6% |
Returns for 10 years | 0.91 | 87.87 | 1% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDT | 73.57 | 0.25 | +0.35% |
First Trust Dev Mkts Ex-US AlphaDEX® ETF | |||
LCG | 31.98 | 0.08 | +0.25% |
Sterling Capital Focus Equity ETF | |||
LIAU | 230.98 | N/A | N/A |
LifeX 2060 Infl-Prt Longevity Inc ETF | |||
NNY | 8.08 | -0.01 | -0.12% |
Nuveen New York Municipal Value Fund | |||
PRF | 43.54 | -0.12 | -0.27% |
Invesco RAFI US 1000 ETF |